The chemical class of FAM75A1 Inhibitors encompasses a diverse array of compounds that can potentially inhibit the activity of the FAM75A1 protein, either directly or indirectly. FAM75A1 is likely involved in cellular processes regulated by signaling pathways such as AMP-activated protein kinase (AMPK), Ca2+/calmodulin-dependent protein kinase kinase (CaMKK), unfolded protein response (UPR), autophagy, and nuclear factor kappa B (NF-κB).
Direct inhibitors such as A769662, Compound C, STO-609, GSK621, Compound 991, PF-06409577, BI-2536, GSK2606414, LDN-192960, 3-Methyladenine, PF-4800567, and QNZ can target specific kinases or signaling molecules involved in these pathways, potentially disrupting cellular processes that rely on FAM75A1 function. Indirect inhibitors exert their effects by modulating cellular responses and signaling cascades that intersect with FAM75A1-mediated pathways, ultimately influencing the activity of FAM75A1. These inhibitors provide valuable tools for investigating the physiological roles of FAM75A1 and may have implications in diseases where dysregulation of FAM75A1-associated pathways occurs.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 is an activator of AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. By activating AMPK, A769662 can inhibit cellular processes that require energy, potentially leading to indirect inhibition of FAM75A1, which may be involved in energy-dependent pathways. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Compound C is a selective inhibitor of AMP-activated protein kinase (AMPK), which regulates various cellular processes including energy metabolism. Inhibition of AMPK by Compound C can disrupt energy homeostasis and downstream signaling pathways, potentially influencing the activity of FAM75A1, which may be linked to energy-dependent processes. | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
STO-609 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaMKK), an upstream activator of AMP-activated protein kinase (AMPK). Inhibition of CaMKK by STO-609 can indirectly suppress AMPK activity, potentially impacting cellular processes regulated by AMPK, including those involving FAM75A1. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $77.00 $153.00 $219.00 $663.00 $1248.00 $4382.00 $7850.00 | 8 | |
Compound 991 is a selective inhibitor of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. Inhibition of AMPK by Compound 991 can disrupt energy-dependent signaling pathways, potentially influencing the activity of FAM75A1, which may be involved in cellular processes sensitive to energy status. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
BI-2536 is a potent inhibitor of Polo-like kinase 1 (PLK1), a regulator of cell cycle progression and mitosis. FAM75A1 may be involved in cell cycle regulation, and inhibition of PLK1 by BI-2536 can potentially disrupt cell cycle dynamics, indirectly affecting FAM75A1-mediated processes related to cell division and proliferation. | ||||||
GSK 2606414 | 1337531-36-8 | sc-490182 sc-490182A | 5 mg 25 mg | $163.00 $572.00 | ||
GSK2606414 is a potent and selective inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), a key mediator of the unfolded protein response (UPR). Inhibition of PERK by GSK2606414 can impact cellular stress responses and signaling pathways, potentially influencing the activity of FAM75A1, which may be modulated by UPR signaling. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine is an inhibitor of autophagy, a cellular process involved in the degradation and recycling of cellular components. FAM75A1 may be associated with autophagy-related pathways, and inhibition of autophagy by 3-Methyladenine can potentially influence the activity of FAM75A1, which may be modulated by autophagy-dependent mechanisms. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
PF-4800567 is a selective inhibitor of receptor-interacting serine/threonine-protein kinase 1 (RIPK1), which plays a role in regulating cell death and inflammation. Inhibition of RIPK1 by PF-4800567 can affect cell survival pathways and inflammatory responses, potentially influencing the activity of FAM75A1, which may be linked to these cellular processes. | ||||||
QNZ | 545380-34-5 | sc-200675 | 1 mg | $117.00 | 12 | |
QNZ is a potent inhibitor of nuclear factor kappa B (NF-κB), a transcription factor involved in the regulation of various cellular processes including inflammation and immunity. Inhibition of NF-κB by QNZ can modulate gene expression profiles and cellular responses, potentially impacting the activity of FAM75A1, which may be regulated by NF-κB-dependent mechanisms. | ||||||